Nordic Health Economics AB was founded in 2003 by Ingela Björholt, who has a doctoral degree within health economics. Her previous career in senior positions within marketing & sales in the pharmaceutical industry provides extensive insight and contacts in the business area.
Since the foundation, the company has attracted a growing group of dedicated professionals with backgrounds in the pharmaceutical industry, the pharmacy profession and academic research institutes. Strong emphasis is placed upon professional excellence, and every senior member of the staff holds a doctoral degree in pharmacology, epidemiology or medicine.
Native speakers of the different languages in the Nordic region belong to the staff, emphasising the company’s ability to provide services and support of customer activities in all Nordic markets.
Since May 2017 the company is part of the PHARMALEX Group. This merger enables us to provide a wider range of services including drug development consulting, regulatory affairs and pharmacovigilance. The PharmaLex Group has over 650 employees in 14 countries worldwide, and more than 650 satisfied clients. Read more about PharmaLex on www.pharmalex.com.
The company is based in Gothenburg, Sweden, with premises on Medicinareberget across the street from the Sahlgrenska University Hospital and in close vicinity of the Medical and the Health & Care Sciences Schools at the University of Gothenburg. A network of renowned clinical experts and academic scientist within health economics and epidemiology forms an external resource of expertise and provides up-to-date insights in the development of the research field.
The company’s core values are integrity and reliability. Our ambition is to produce creative, high-quality work meeting the highest standards of scientific rigor and real-world applicability.
Projects are performed in close collaboration with our clients throughout the process, to ensure a smooth workflow from project take-off to timely delivery of end product.